Profile
G.
Bryan Cornwall worked as Vice President-Research & Technology at MacroPore Biosurgery, Inc. from 2000 to 2004.
He then worked as Senior VP-Clinical Operations & Research at NuVasive, Inc. from 2004 to 2015.
After that, he became an Associate Professor-Mechanical Engineering at the University of San Diego.
Currently, he is working as Executive VP-Research & Clinical Affairs at Surgalign Holdings, Inc. Dr. Cornwall received his undergraduate, graduate, and doctorate degrees from Queen's University.
Former positions of G. Cornwall
| Companies | Position | End |
|---|---|---|
| SURGALIGN HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 02/10/2023 |
| NUVASIVE, INC. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
| MacroPore Biosurgery, Inc. /Old/ | Chief Tech/Sci/R&D Officer | 01/01/2004 |
| University of San Diego | Corporate Officer/Principal | - |
Training of G. Cornwall
| Queen's University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| MacroPore Biosurgery, Inc. /Old/ | Health Technology |
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
Surgalign Holdings, Inc.
 Surgalign Holdings, Inc. Medical SpecialtiesHealth Technology Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL. | Health Technology |
- Stock Market
- Insiders
- G. Cornwall